Related Experiment Video
Updated: Jan 21, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
6.2K
[Diabetes treatment 2.0: telemedicine]
A Waschkau1, T Uebel2, J Steinhäuser3
1Institut für Allgemeinmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, Haus 50, 23538, Lübeck, Deutschland. alexander.waschkau@uni-luebeck.de.
Der Internist
|July 27, 2019
Summary
Most diabetes telemedical applications (TA) in Germany lack structured research evaluation. While some TA projects report on outcomes like HbA1c, few use established evaluation models, hindering routine care integration.
Area of Science:
- Digital Health
- Medical Informatics
- Diabetes Management
Background:
- Diabetes mellitus affects 5.8-9.5% of Germany's population.
- Telemedical applications (TA) offer potential for diabetes care but face limited research evaluation.
- Lack of structured evaluation hinders the integration of TA into routine diabetes management.
Purpose of the Study:
- To identify research evaluation approaches in current telemedical applications for diabetes therapy.
- To assess the extent of structured research evaluation in diabetes-focused TA.
Main Methods:
- Searched the 'vesta' portal, Innovation Fund websites, PubMed, and gray literature for telemedical diabetes projects.
- Focused on evaluation approaches, excluding prevention projects.
- Identified 12 relevant projects for analysis.
Main Results:
- Only 4 of the 12 identified projects had available research evaluation data.
- These 4 projects reported on parameters including HbA1c, quality of life, and economic aspects.
- One project utilized an established TA evaluation model; 8 projects lacked evaluation data, with 3 still collecting data.
Conclusions:
- Most telemedically supported diabetes projects currently lack structured research evaluation.
- There is a need for established instruments for the systematic evaluation of TA in diabetes care.
- Improved evaluation is crucial for the wider adoption of TA in routine diabetes management.
Related Concept Videos
01:20Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
01:15Diabetes: Management and Pharmacotherapy
875
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
875
01:19Psychoneuroimmunology: Diabetes and Cancer
464
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
464
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
01:22Diabetes Mellitus: Type 2 and Gestational
4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.0K